Committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients Company presentation Latest news and press releases ALL202120202019201820172016 21. Oct. 2021 Oncoinvent to present four posters at the 34th Annual Congress of the European Association of Nuclear Medicine 4. Oct. 2021 Oncoinvent Strengthens Leadership Team This is the preview of the ... Read more
Location: Norway, Oslo
Employees: 11-50
Total raised: $25M
Founded date: 2010
Investors 3
| Date | Name | Website |
| 27.01.2023 | Planet 9 C... | planet9ven... |
| - | Hadean Ven... | hadeanvent... |
| - | Farvatn Ve... | farvatnven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.02.2017 | - | $25M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 29.06.2021 | Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Fu... | Norwegian radiopharmaceutical company announces successful closing of a private placement that will... | hadeanvent... |
| 09.04.2021 | Safety Monitoring Committee Approves 7 MBq as Recommended Cl... | 7MBq dose of Radspherin® determined to be safe, and approved by the SMC as the recommended clinical ... | hadeanvent... |
| 11.01.2021 | Oncoinvent Announces Advancement of Radspherin® to Final Dos... | Safety Monitoring Committee review of third dose-level cohort allows progression of Phase 1 RAD-18-0... | hadeanvent... |
| 27.05.2020 | Oncoinvent Raises 40M NOK Financing Round | Oncoinvent AS, an Oslo, Norway-based developer of new products to provide treatment options to cance... | finsmes.co... |
| 14.02.2017 | Term Sheet — Tuesday, February 14 | OPEN MIC It’s feedback time. Paid Content Securing the enterprise without boundaries From ExtraHop …... | fortune.co... |
| 13.02.2017 | Oncoinvent Raises $25M in Equity Funding | Oncoinvent, an Oslo, Norway-based developer of cancer therapeutics, raised around $25m in new equity... | finsmes.co... |